EXPLORING THE UTILITY OF CSF NEUROGRANIN LEVELS IN AN ALZHEIMER’S DISEASE CLINICAL TRIALJeffrey L. Dage,Peter F. Castelluccio,Wesley Anderson,Peng Yu, Jayne Talbot,Bradley B. Miller,Elizabeth M. Herries,Dan Crimmins,Jack H. Ladenson,Anne M. Fagan,David M. Holtzman,David B. Henley,Eric R. Siemers,Robert A. DeanAlzheimers & Dementia(2016)引用 0|浏览67暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要